Agenus to Report Fourth Quarter and Year End 2013 Financial Results on March 5, 2014; Conference Call to Follow
February 27 2014 - 4:00PM
Business Wire
Agenus Inc. (NASDAQ: AGEN) will release its fourth quarter and
year end 2013 financial results before the market opens on March 5,
2014.
Agenus executives will host a conference call at 11:00 a.m.
Eastern Time that same day. To access the live call, dial
647-426-1845. The call will also be webcast and will be accessible
from the company’s website at www.agenusbio.com/webcast/. A replay
will be available approximately two hours after the call through
midnight Eastern Time on May 5, 2014. The replay number is
416-915-1035, and the access code is 498676. The replay will also
be available on the company’s website approximately two hours after
the live call.
About Agenus
Agenus is a biopharmaceutical company focused on immuno-oncology
with a portfolio of checkpoint modulators and anti-cancer vaccines.
The company’s three platforms include checkpoint modulators, heat
shock protein based vaccines, and adjuvants. The company’s
proprietary discovery engine Retrocyte Display® generates high
quality therapeutic antibody drug candidates quickly using a
high-throughput approach incorporating full-length IgG format human
antibody libraries expressed in mammalian B-lineage cells. A
portfolio of checkpoint modulator programs is advancing in
preclinical development, several heat shock protein vaccines are in
Phase 2 studies, and the QS-21 Stimulon® adjuvant platform is
extensively partnered with GlaxoSmithKline and Janssen and includes
several candidates in late-stage trials. Among Agenus and its
partners, 23 programs are in clinical development. For more
information, please visit www.agenusbio.com, or connect with the
company on Facebook, LinkedIn, Twitter and Google+.
Media and Investor Contact:Agenus Inc.Jonae R. Barnes,
617-818-2985Vice PresidentInvestor Relations and Corporate
Communicationsjonae.barnes@agenusbio.com
Agenus (NASDAQ:AGEN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Agenus (NASDAQ:AGEN)
Historical Stock Chart
From Jul 2023 to Jul 2024